According to Cardiovascular Systems's latest financial reports the company's current revenue (TTM) is $0.23 B. In 2021 the company made a revenue of $0.25 B an increase over the years 2020 revenue that were of $0.22 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2022 (TTM) | $0.23 B | -4.74% |
2021 | $0.25 B | 10.21% |
2020 | $0.22 B | -13.59% |
2019 | $0.26 B | 14.34% |
2018 | $0.23 B | 11.5% |
2017 | $0.20 B | 7.58% |
2016 | $0.19 B | 6.66% |
2015 | $0.18 B | 12.53% |
2014 | $0.16 B | 36.8% |
2013 | $0.11 B | 26.62% |
2012 | $92.71 M | 15.55% |
2011 | $80.23 M | 12.29% |
2010 | $71.45 M | 16.94% |
2009 | $61.1 M | |
2006 | $15.98 M | 3525.4% |
2005 | $0.44 M | -47.12% |
2004 | $0.83 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $93.02 B | 38,684.54% | ๐บ๐ธ USA |
Medtronic MDT | $32.32 B | 13,375.48% | ๐ฎ๐ช Ireland |
Boston Scientific BSX | $14.24 B | 5,837.22% | ๐บ๐ธ USA |
Merit Medical MMSI | $1.25 B | 424.25% | ๐บ๐ธ USA |
LeMaitre Vascular LMAT | $0.19 B | -19.33% | ๐บ๐ธ USA |
AngioDynamics ANGO | $0.32 B | 35.09% | ๐บ๐ธ USA |